Drugs / hu14.18-IL2 fusion protein
hu14.18-IL2 fusion protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01334515 | Sep 2011 → Dec 2013 | neuroblastoma | Children's Oncology Group | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hu14.18-IL2 fusion protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01334515 ↗ |
| Modality | Protein / enzyme biologic | “hu14.18-IL2 fusion protein” NCT01334515 ↗ |
| Route | Intravenous | “hu14.18-IL2 fusion protein IV over 4 hours on days 4-6” NCT01334515 ↗ |